MaxLinear Inc. Common Stock vs Roivant Sciences Ltd. Common Shares — how do they compare? MaxLinear Inc. Common Stock trades at $93.49 (market cap $8.50B), while Roivant Sciences Ltd. Common Shares trades at $34.21 (market cap $24.72B). The key difference: Roivant Sciences Ltd. Common Shares is far larger — about 2.9× MaxLinear Inc. Common Stock's market cap, and Roivant Sciences Ltd. Common Shares is more actively traded (6,279,442 versus 4,008,439). Which is the better fit depends on your goals — on Pluang, investors hold MaxLinear Inc. Common Stock for 0 Days and Roivant Sciences Ltd. Common Shares for 0 Days on average.
| MXL | ROIV | |
|---|---|---|
Market Cap | $8.50B | $24.72B |
Volume | 4,008,439 | 6,279,442 |
Sector | Technology | Health |
52-Week High | $128.03 | $41.81 |
52-Week Low | $13.05 | $16.04 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $8.58B | $20.99B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
MaxLinear develops analog and mixed-signal semiconductors for connectivity, communications, industrial, and data center applications.
Read more on MXL →Roivant Sciences develops medicines by building and supporting biotechnology subsidiaries, known as Vants. Its programs span areas such as immunology, neuroscience, and rare diseases.
Read more on ROIV →